Istituti Clinici Scientifici Maugeri SpA

Pavia, Lombardy

Oncologyliquid biopsyGrant-only

What changed

Study registered, no phase assigned: Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy

1w agoTrial registeredJul 6, 2026Source filing (opens the source filing in a new tab)

Momentum

93no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
Study registered
Dec 1, 2022
Breast Cancer · RECRUITING · sponsor: Istituti Clinici Scientifici Maugeri SpA · Circulating Tumour Cells Characterization in Breast Cancer Patients
ClinicalTrials.gov · NCT06048835 (opens the source filing in a new tab)
Trial
Study registered
May 11, 2021
Breast Cancer · RECRUITING · sponsor: Istituti Clinici Scientifici Maugeri SpA · Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy
ClinicalTrials.gov · NCT05831397 (opens the source filing in a new tab)
Trial
Study registered
Dec 1, 2020
Breast Cancer · RECRUITING · sponsor: Istituti Clinici Scientifici Maugeri SpA · Characterization of Extracellular Vesicles in Breast Cancer Patients
ClinicalTrials.gov · NCT05798338 (opens the source filing in a new tab)
Trial
Study registered
Feb 4, 2020
Breast Cancer · ACTIVE_NOT_RECRUITING · sponsor: Istituti Clinici Scientifici Maugeri SpA · Predictive Model of Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast Cancer Patients
ClinicalTrials.gov · NCT05798806 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 58%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 1.00{"reasons":["name similarity 100%","semantic similarity 98%","shared principal investigator / founder","same city","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 1.00{"reasons":["name similarity 100%","shared principal investigator / founder","same city","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.78{"reasons":["name similarity 100%","shared principal investigator / founder","same city","same therapeutic area"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy
1w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Predictive Model of Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast Cancer Patients
1w agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Circulating Tumour Cells Characterization in Breast Cancer Patients
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Circulating Tumour Cells Characterization in Breast Cancer Patients
3w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Characterization of Extracellular Vesicles in Breast Cancer Patients
7mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Characterization of Extracellular Vesicles in Breast Cancer Patients
7mo agoTrial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources